skip to content
Towards the elimination of chronic viral hepatitis in Europe : prevalence, risk groups and screening strategies Preview this item
ClosePreview this item
Checking...

Towards the elimination of chronic viral hepatitis in Europe : prevalence, risk groups and screening strategies

Author: Abby Falla
Publisher: Erasmus University Rotterdam 2018-04-20
Edition/Format: Book Book : English
Summary:
markdownabstractThis thesis aims to contribute strategic information towards the elimination of chronic viral hepatitis in the European Union/European Economic Area (EU/EEA). Many EU/EEA countries have successfully controlled the transmission of HBV/HCV and the incidence of new infections is declining. This declining incidence exists alongside a projected increase in mortality due to disease progression and ageing  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Find a copy online

Links to this item

Find a copy in the library

We were unable to get information about libraries that hold this item.

Details

Document Type: Book
All Authors / Contributors: Abby Falla
ISBN: 978-94-6295-944-6
Language Note: English
Unique Identifier: 8086545097
Awards:

Abstract:

markdownabstractThis thesis aims to contribute strategic information towards the elimination of chronic viral hepatitis in the European Union/European Economic Area (EU/EEA). Many EU/EEA countries have successfully controlled the transmission of HBV/HCV and the incidence of new infections is declining. This declining incidence exists alongside a projected increase in mortality due to disease progression and ageing among the infected population. This dichotomy presents a public health challenge to countries: how to identify and retain in care people with a chronic viral hepatitis infection. This thesis is focused around the first three strategic pillars of the World Health Organisation’s 2016 elimination strategy: the who and where; the what; and the how. There are two broad aims: 1. To understand the epidemiology of chronic viral hepatitis in the general population and among risk groups in the EU/EEA; 2. To understand the health system conditions and screening interventions that effectively reach, diagnose and retain at-risk migrants in health care for viral hepatitis. Drawing on a range of methodological techniques from epidemiology, public health and the social sciences, we strive to answer the following three research questions: 1. To what extent are migrants from endemic countries a risk group for chronic hepatitis B and C in Europe? 2. What can be learned from different migrant-focused models of HBV/HCV screening? 3. What are the key conditions to maximise the impact public health of HBV/HCV screening among migrants?

Reviews

User-contributed reviews

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


\n\n

Primary Entity<\/h3>\n
<http:\/\/www.worldcat.org\/oclc\/8086545097<\/a>> # Towards the elimination of chronic viral hepatitis in Europe : prevalence, risk groups and screening strategies<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Book<\/a>, schema:CreativeWork<\/a> ;\u00A0\u00A0\u00A0\nlibrary:oclcnum<\/a> \"8086545097<\/span>\" ;\u00A0\u00A0\u00A0\nrdfs:comment<\/a> \"949 $l doctoralthesis<\/span>\" ;\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9082556721#Thing\/hepatitis_c<\/a>> ; # hepatitis C<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9082556721#Thing\/europe<\/a>> ; # Europe<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9082556721#Thing\/hepatitis_b<\/a>> ; # hepatitis B<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9082556721#Thing\/migrants<\/a>> ; # migrants<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9082556721#Thing\/screening<\/a>> ; # screening<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9082556721#Thing\/risk_groups<\/a>> ; # risk groups<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9082556721#Thing\/chronic_viral_hepatitis<\/a>> ; # Chronic viral hepatitis<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9082556721#Thing\/treatment<\/a>> ; # treatment<\/span>\n\u00A0\u00A0\u00A0\nschema:creator<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9082556721#Person\/falla_abby<\/a>> ; # Abby Falla<\/span>\n\u00A0\u00A0\u00A0\nschema:datePublished<\/a> \"2018\/04\/20<\/span>\" ;\u00A0\u00A0\u00A0\nschema:description<\/a> \"markdownabstractThis thesis aims to contribute strategic information towards the elimination of chronic viral hepatitis in the European Union\/European Economic Area (EU\/EEA). Many EU\/EEA countries have successfully controlled the transmission of HBV\/HCV and the incidence of new infections is declining. This declining incidence exists alongside a projected increase in mortality due to disease progression and ageing among the infected population. This dichotomy presents a public health challenge to countries: how to identify and retain in care people with a chronic viral hepatitis infection. This thesis is focused around the first three strategic pillars of the World Health Organisation\u2019s 2016 elimination strategy: the who and where; the what; and the how. There are two broad aims: 1. To understand the epidemiology of chronic viral hepatitis in the general population and among risk groups in the EU\/EEA; 2. To understand the health system conditions and screening interventions that effectively reach, diagnose and retain at-risk migrants in health care for viral hepatitis. Drawing on a range of methodological techniques from epidemiology, public health and the social sciences, we strive to answer the following three research questions: 1. To what extent are migrants from endemic countries a risk group for chronic hepatitis B and C in Europe? 2. What can be learned from different migrant-focused models of HBV\/HCV screening? 3. What are the key conditions to maximise the impact public health of HBV\/HCV screening among migrants?<\/span>\" ;\u00A0\u00A0\u00A0\nschema:exampleOfWork<\/a> <http:\/\/worldcat.org\/entity\/work\/id\/9082556721<\/a>> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Towards the elimination of chronic viral hepatitis in Europe : prevalence, risk groups and screening strategies<\/span>\" ;\u00A0\u00A0\u00A0\nschema:productID<\/a> \"8086545097<\/span>\" ;\u00A0\u00A0\u00A0\nschema:publication<\/a> <http:\/\/www.worldcat.org\/title\/-\/oclc\/#PublicationEvent\/erasmus_university_rotterdam2018_04_20<\/a>> ;\u00A0\u00A0\u00A0\nschema:publisher<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9082556721#Agent\/erasmus_university_rotterdam<\/a>> ; # Erasmus University Rotterdam<\/span>\n\u00A0\u00A0\u00A0\nschema:url<\/a> <http:\/\/hdl.handle.net\/1765\/105369<\/a>> ;\u00A0\u00A0\u00A0\nschema:workExample<\/a> <http:\/\/worldcat.org\/isbn\/978-94-6295-944-6<\/a>> ;\u00A0\u00A0\u00A0\nwdrs:describedby<\/a> <http:\/\/www.worldcat.org\/title\/-\/oclc\/8086545097<\/a>> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n\n

Related Entities<\/h3>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9082556721#Agent\/erasmus_university_rotterdam<\/a>> # Erasmus University Rotterdam<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nbgn:Agent<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Erasmus University Rotterdam<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9082556721#Person\/falla_abby<\/a>> # Abby Falla<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Person<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Abby Falla<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9082556721#Thing\/chronic_viral_hepatitis<\/a>> # Chronic viral hepatitis<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Thing<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Chronic viral hepatitis<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9082556721#Thing\/europe<\/a>> # Europe<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Thing<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Europe<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9082556721#Thing\/hepatitis_b<\/a>> # hepatitis B<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Thing<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"hepatitis B<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9082556721#Thing\/hepatitis_c<\/a>> # hepatitis C<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Thing<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"hepatitis C<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9082556721#Thing\/migrants<\/a>> # migrants<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Thing<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"migrants<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9082556721#Thing\/risk_groups<\/a>> # risk groups<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Thing<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"risk groups<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9082556721#Thing\/screening<\/a>> # screening<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Thing<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"screening<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/9082556721#Thing\/treatment<\/a>> # treatment<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Thing<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"treatment<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/hdl.handle.net\/1765\/105369<\/a>>\u00A0\u00A0\u00A0\nrdfs:comment<\/a> \"NARCIS<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/worldcat.org\/isbn\/978-94-6295-944-6<\/a>>\u00A0\u00A0\u00A0\u00A0a \nschema:ProductModel<\/a> ;\u00A0\u00A0\u00A0\nschema:isbn<\/a> \"978-94-6295-944-6<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/www.worldcat.org\/title\/-\/oclc\/#PublicationEvent\/erasmus_university_rotterdam2018_04_20<\/a>>\u00A0\u00A0\u00A0\u00A0a \nschema:PublicationEvent<\/a> ;\u00A0\u00A0\u00A0\nschema:organizer<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/9082556721#Agent\/erasmus_university_rotterdam<\/a>> ; # Erasmus University Rotterdam<\/span>\n\u00A0\u00A0\u00A0\nschema:startDate<\/a> \"2018-04-20<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/www.worldcat.org\/title\/-\/oclc\/8086545097<\/a>>\u00A0\u00A0\u00A0\u00A0a \ngenont:InformationResource<\/a>, genont:ContentTypeGenericResource<\/a> ;\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/www.worldcat.org\/oclc\/8086545097<\/a>> ; # Towards the elimination of chronic viral hepatitis in Europe : prevalence, risk groups and screening strategies<\/span>\n\u00A0\u00A0\u00A0\nschema:dateModified<\/a> \"2019-05-18<\/span>\" ;\u00A0\u00A0\u00A0\nvoid:inDataset<\/a> <http:\/\/purl.oclc.org\/dataset\/narcis<\/a>> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n\n

Content-negotiable representations<\/p>\n